Related Experiment Video
Updated: Feb 24, 2026

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method
Published on: July 4, 2021
Cerebral Sinovenous Thrombosis
1Department of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, United States.
Insights
Cerebral sinovenous thrombosis (CSVT) is a rare pediatric cerebrovascular disorder with varied causes and symptoms by age. Treatment, especially in newborns, remains challenging, with ongoing research into therapies like endovascular treatment.
Area of Science:
- Pediatric Neurology
- Cerebrovascular Diseases
- Thrombosis
Background:
- Cerebral sinovenous thrombosis (CSVT) is a rare but severe cerebrovascular condition in children.
- Incidence is ~0.6/100,000/year, with 30-50% in newborns.
- Causes and symptoms vary significantly with age.
Purpose of the Study:
- To provide updated information on risk factors, clinical presentations, and treatment practices for childhood CSVT.
- To highlight treatment uncertainties, particularly for neonatal CSVT.
- To discuss the emerging role of endovascular therapy.
Main Methods:
- Review of recent multicenter cohort studies from North America and Europe.
- Analysis of data on risk factors, clinical presentations, and treatment outcomes.
- Synthesis of current guidelines and expert opinions on management.
Main Results:
- Neonatal CSVT risk factors include acute systemic illness; childhood CSVT is linked to infections or chronic diseases.
- Newborns present with seizures/altered mental status; children/adolescents with headache/vomiting/lethargy.
- Systemic anticoagulation is common, but practices vary; endovascular therapy is reserved for severe, refractory cases.
Conclusions:
- CSVT management in children, especially neonates, presents significant challenges due to hemorrhage risk and long-term morbidity.
- Further research is needed to clarify optimal treatment strategies, including endovascular approaches.
- Continued research in childhood cerebrovascular disease promises improved understanding and outcomes.
Abstract:
Cerebral sinovenous thrombosis (CSVT) is a rare but serious cerebrovascular disorder affecting children from the newborn period through childhood and adolescence. The incidence is estimated at 0.6/100,000/year, with 30-50% occurring in newborns. Causes are diverse and are highly age dependent. Acute systemic illness is the dominant risk factor among newborns. In childhood CSVT, acute infections of the head and neck such as mastoiditis are most common, followed by chronic underlying diseases such as nephrotic syndrome, cancer, and inflammatory bowel disease. Signs and symptoms are also age related. Seizures and altered mental status are the commonest manifestations in newborns. Headache, vomiting, and lethargy, sometimes with 6th nerve palsy, are the most common symptoms in children and adolescents. Recent multicenter cohort studies from North America and Europe have provided updated information on risk factors, clinical presentations, treatment practices, and outcomes. While systemic anticoagulation is the most common specific treatment used, there are wide variations and many uncertainties even among experts concerning best practice. The treatment dilemma is especially pronounced for neonatal CSVT. This is due in part to the higher prevalence of intracranial hemorrhage among newborns on the one hand, and the clear evidence that newborns suffer greater long-term neurologic morbidity on the other hand. With the advent of widespread availability and acceptance of acute endovascular therapy for arterial ischemic stroke, there is renewed interest in this therapy for children with CSVT. Limited published evidence exists regarding the benefits and risks of these invasive therapies. Therefore, the authors of current guidelines advise reserving this therapy for children with progressive and severe disease who have failed optimal medical management. As research focused on childhood cerebrovascular disease continues to grow rapidly, the future prospects for improving knowledge about this disorder should be good.
Related Concept Videos
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...
Venous Thrombosis III: Interprofessional Care
Overview of Systemic Veins
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...

